4 completed, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
Follow BI 6727: new trials by email Literature Review of BI 6727 trials Research Report on BI 6727
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Volasertib, Cytarabine, Daunorubicin - Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) | Phase 2 | Terminated | University of Ulm | 6 | 2016-02-01 | 2018-02-28 |
| BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer Paclitaxel, Gemcitabine, Topotecan - Ovarian Neoplasms | Phase 2 | Completed | Boehringer Ingelheim | 110 | 2010-04-01 | 2015-08-13 |
| Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer BI 6727, IV infusion - Neoplasms | Phase 2 | Completed | Boehringer Ingelheim | 50 | 2009-11-19 | 2017-11-22 |
| Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC pemetrexed, BI 6727 - Carcinoma, Non-Small-Cell Lung | Phase 2 | Completed | Boehringer Ingelheim | 143 | 2009-03-01 | 2016-09-20 |
| Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid Leukaemia Volasertib, Cytarabine - Leukemia, Myeloid, Acute | Phase 2 | Completed | Boehringer Ingelheim | 180 | 2008-11-27 | 2023-10-03 |
Leukemia, Myeloid, Acute (2) · Carcinoma, Non-Small-Cell Lung (1) · Neoplasms (1) · Ovarian Neoplasms (1)
Boehringer Ingelheim (4) · University of Ulm (1)
Belgium (2) · Canada (2) · France (2) · Germany (2) · Austria (1) · Italy (1) · Norway (1) · Slovakia (1) · Spain (1) · Sweden (1) · Taiwan (1) · The Bahamas (1) · United States (1)
PMID 24339028, PMID 25006120, PMID 26100229, PMID 26755507, PMID 37407274
2008 (1), 2009 (1), 2014 (1)